GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Dividend Yield %

Celadon Pharmaceuticals (LSE:CEL) Dividend Yield % : 0.00% (As of May. 21, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Dividend Yield %?

As of today (2024-05-21), the Trailing Annual Dividend Yield of Celadon Pharmaceuticals is 0.00%.

The historical rank and industry rank for Celadon Pharmaceuticals's Dividend Yield % or its related term are showing as below:

LSE:CEL's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.68
* Ranked among companies with meaningful Dividend Yield % only.

Celadon Pharmaceuticals's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00.

As of today (2024-05-21), the Forward Dividend Yield % of Celadon Pharmaceuticals is 0.00%.

Celadon Pharmaceuticals's Dividends per Share for the six months ended in Dec. 2023 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Celadon Pharmaceuticals Dividend Yield % Historical Data

The historical data trend for Celadon Pharmaceuticals's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Dividend Yield % Chart

Celadon Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Yield %
- - - - -

Celadon Pharmaceuticals Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Dividend Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Celadon Pharmaceuticals's Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celadon Pharmaceuticals's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's Dividend Yield % falls into.



Celadon Pharmaceuticals Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Celadon Pharmaceuticals  (LSE:CEL) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Celadon Pharmaceuticals Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Celadon Pharmaceuticals (LSE:CEL) Business Description

Traded in Other Exchanges
N/A
Address
32-33 Cowcross Street, London, GBR, EC1M 6DF
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines